Ariel Kleman is an Oncology physician affiliated with Medical College of Wisconsin. OpenAlex indexes 17 publications with 231 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
9200 W Wisconsin Avenue
Milwaukee, WI 532072141
Telephone
414-955-8296Provider last certified this registry record 3 Jan 2025.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Geron CorporationProgram year20251 payment
- Exelixis Inc.Program year20231 payment
- Genmab U.S., Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
42.9%Aromatase Inhibitor30.4%Anastrozole70%Letrozole30%Part D≥52 patientsCytochrome P450 17A1 Inhibitor3.5%Abiraterone Acetate100%Part D<11 patients+ 4 more classes in this area
Metabolism & gastrointestinal
21.4%Corticosteroid5.9%Prednisone100%Part D≥13 patientsSerotonin-3 Receptor Antagonist4.5%Ondansetron Hcl100%Part D≥35 patients+ 4 more classes in this area
Blood & clotting
14.1%Factor Xa inhibitor10.4%Eliquis100%Part D≥24 patientsLow Molecular Weight Heparin2%Enoxaparin Sodium100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A multicenter retrospective study of 223 patients with t(14;16) in multiple myeloma
American Journal of Hematology
2020 - Different MAF translocations confer similar prognosis in newly diagnosed multiple myeloma patients
Leukemia & lymphoma/Leukemia and lymphoma
2020 - Propylene Glycol-Free Melphalan versus PG-Melphalan as Conditioning for Autologous Hematopoietic Cell Transplantation for Myeloma
Biology of Blood and Marrow Transplantation
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Razelle Kurzrock, MD
Medical College of Wisconsin
Mary Horowitz, MD
Medical College of Wisconsin
Janet Rader, MD
Medical College of Wisconsin
Bruce Camitta, MD
Medical College of Wisconsin
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”